Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Førsund, Mette S."'
Autor:
Spasevska, Ivana, Sharma, Ankush, Steen, Chloé B., Josefsson, Sarah E., Blaker, Yngvild N., Kolstad, Arne, Rustad, Even H., Meyer, Saskia, Isaksen, Kathrine, Chellappa, Stalin, Kushekhar, Kushi, Beiske, Klaus, Førsund, Mette S., Spetalen, Signe, Holte, Harald, Østenstad, Bjørn, Brodtkorb, Marianne, Kimby, Eva, Olweus, Johanna, Taskén, Kjetil, Newman, Aaron M., Lorenz, Susanne, Smeland, Erlend B., Alizadeh, Ash A., Huse, Kanutte, Myklebust, June H.
Publikováno v:
In Blood Advances 12 December 2023 7(23):7216-7230
Autor:
Wang, Zhihui1, Førsund, Mette S.1, Holm, Ruth1, Slipicevic, Ana1, Trope, Claes G.2, Nesland, Jahn M.3
Publikováno v:
Cancer Medicine. Aug2018, Vol. 7 Issue 8, p3955-3964. 10p.
Autor:
Josefsson, Sarah Elisabet, Beiske, Klaus, Blaker, Yngvild Nuvin, Førsund, Mette S, Holte, Harald, Østenstad, Bjørn, Kimby, Eva, Köksal, Hakan, Wälchli, Sébastien, Bai, Baoyan, Smeland, Erlend B, Levy, Ronald, Kolstad, Arne, Huse, Kanutte, Myklebust, June
Publikováno v:
Josefsson, Sarah Elisabet Beiske, Klaus Blaker, Yngvild Nuvin Førsund, Mette S Holte, Harald Østenstad, Bjørn Kimby, Eva Köksal, Hakan Wälchli, Sébastien Bai, Baoyan Smeland, Erlend B Levy, Ronald Kolstad, Arne Huse, Kanutte Myklebust, June . TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer immunology research. 2019, 7(3), 355-362
Cancer immunology research
Cancer immunology research
Autor:
Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Beiske K; Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Blaker YN; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Førsund MS; Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Holte H; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Østenstad B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Kimby E; Department of Hematology, Karolinska Institutet, Stockholm, Sweden., Köksal H; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Section for Cellular Therapy, Department for Cancer Treatment, Oslo University Hospital, Oslo, Norway., Wälchli S; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Section for Cellular Therapy, Department for Cancer Treatment, Oslo University Hospital, Oslo, Norway., Bai B; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Levy R; Division of Oncology, Stanford School of Medicine, Stanford, California., Kolstad A; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Huse K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. June.Helen.Myklebust@rr-research.no.; KG Jebsen Centre for B-cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Mar; Vol. 7 (3), pp. 355-362. Date of Electronic Publication: 2019 Jan 18.